Bison Wealth, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Bison Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$151.41 - $196.57 $200,315 - $260,062	-1,323 Reduced 51.82%	1,230 $235,000
Q3 2023 Nov 13, 2023	SELL	$170.77 - $211.65 $368,350 - $456,529	-2,157 Reduced 45.8%	2,553 $452,000
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $28,491 - $32,655	154 Added 3.38%	4,710 $894,000
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $3,653 - $4,710	-20 Reduced 0.44%	4,556 $912,000
Q4 2022 Feb 10, 2023	SELL	$185.53 - $241.31 $350,466 - $455,834	-1,889 Reduced 29.22%	4,576 $1.09 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $895,661 - $1.5 Million	6,465 New	6,465 $1.29 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Bison Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Bison Wealth, LLC with notifications on news.